Research Insights

Subthalamic Stimulation, Apomorphine, and Levodopa Infusion in Parkinson’s Disease

Citation: Dafsari, H. S., Martinez‐Martin, P., Rizos, A., Trost, M., dos Santos Ghilardi, M. G., Reddy, P., & Barbe, M. T. (2019). EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson’s disease. Movement Disorders, s34(3), 353-365.

Introduction:

The aim of this study was to compare 3 well-established, safe and effective treatments for symptoms in Parkinson’s Disease (PD) to assist with improving quality of life. This is the first study to compare the different treatment effects of the following 3 therapeutic strategies in individuals with PD:

  • Deep Brain Stimulation of the subthalamic nucleus (STN-DBS)
  • Intrajejunal levodopa infusion (IJLI)
  • Apomorphine infusion (APO)

Click here to read the full article.

Back

Follow Us Follow us on TwitterFollow us on FacebookInstagram

Sign Up for Email Alerts

By providing your email you agree to receive periodic emails from The Parkinson Alliance.

Please tell us more about yourself:

This month is? (Anti-Spam)

Contact UsTerms Of UsePrivacy Policy

The Parkinson Alliance is a nonprofit, tax-exempt charitable organization under section 501(c)(3) of the Internal Revenue Code. Donations are tax-deductible as allowed by law. Copyright © 2018 The Parkinson Alliance. All rights reserved.